M&A Deal Summary |
|
---|---|
Date | 2020-09-03 |
Target | PKG |
Sector | Medical Products |
Buyer(s) | Cerebain Biotech |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2007 |
Sector | Medical Products |
Employees | 2 |
Cerebain Biotech is a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device and a synthetic drug solution. The device leverages the clinically observable, positive impact that Omentum stimulation has on cognitive function as related to dementias, and in particular, Alzheimer’s disease. Cerebain Biotech was formed in 2007 and is based in Costa Mesa, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Idaho) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2020) | 1 of 1 |